BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230110
DTEND;VALUE=DATE:20230113
DTSTAMP:20260516T045532
CREATED:20221007T084856Z
LAST-MODIFIED:20221007T084856Z
UID:35427-1673308800-1673567999@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes and Injectable Drug Devices Europe
DESCRIPTION:SAE Media Group’s 15th Annual Conference \nPre-Filled Syringes and Injectable Drug Devices Europe \nJanuary 10 – 12 2023 | London\, UK \nhttp://www.pre-filled-syringes.com/pharmajournalist \n————————————————————————- \nThe pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity\, aid self-administration and deliver biologics that have large-volumes and novel formulations. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma\, device developers and regulators can work together to encourage innovation. \n \nSAE Media Group’s 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever\, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below: \n\nNovel Drug Products and Large Volume Delivery\nSustainability for Injectable Delivery Devices\nPrimary Packaging Development\nConnected Drug Delivery Devices\n\nTopics of discussion will include the latest updates in the combination product regulatory framework\, insights into the evolving digital health landscape for connected delivery devices\, considerations for the development of primary packaging\, utilising platform technology\, the delivery of novel drug formulations and large volume drug products\, patient centric approaches to device design as well as sustainable approaches for device development. \nThis event will not only bring you key insights you need to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. \nBenefits of Attending: \n\nEngage with industry representatives on the latest trends within the pre-filled syringe and injectable device market\nHear about new technological advances in the delivery of large volume drugs\nExplore updates to drug device combination product design approaches considering patient preference at the forefront with case studies from big pharma representatives\nUnderstand the latest regulatory requirements from regulatory experts surrounding medical devices and digital health\nDelve into the considerations for material components for the development of primary packaging\nGain insight into how big pharma are incorporating sustainable approaches into drug device design\n\nWho should attend: \nAdvanz Pharma; AstraZeneca; Balda Medical GmbH & Co. KG; Bayer AG; Bayer Pharma; BD Medical; BD Medical – Pharmaceutical Systems; Becton Dickinson (BD); Boehringer Ingelheim; Boehringer Ingelheim GmbH & Co. KG; Boehringer Ingelheim Pharma GmbH & CO KG; Boehringer Ingelheim Pharma Gmbh & Co. Kg; BSI; BSI Group; Chiesi Ltd; Crux Product Design Ltd; DCA Design International; Device Development; Dr.Reddys; GlaxoSmithKline; GSK; Hoffmann-La Roche; Horizon Therapeutics GmbH; Ichnos Sciences; Janssen Pharmaceutical Companies; Johnson & Johnson; Johnson & Johnson (Janssen Pharmaceutical); Medincell; Merck Group; Midas Pharma Gmbh; Nemera; Novartis; Novo Nordisk; Novo Nordisk A/S; Owen Mumford; Pfizer; Pfizer UK; PharmaEssentia; Prescient Healthcare Group; RAUMEDIC AG; Sanofi; SCHOTT AG; SPM MEDICARE PVT LTD\, INDIA; Sustainable Healthcare Coalition; Takeda; Teva; Teva Pharmaceuticals; Teva Pharmaceuticals Industries Ltd.; Teva\, Combination Products; TUV Italia SRL; TUV SUD Japan Ltd.; TUV SUD Product Service GmbH; University of Liverpool; University of Southern Denmark; Zeon Europe GmbH; Zeon Specialty Materials ; \nSAE Media Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. \nFor details\, please contact Daniele Moreschi on: +44 (0)20 7827 6050 or dmoreschi@smi-online.co.uk \nFor all delegate enquiries\, contact Jamie Wilkinson on: +44 (0) 20 7827 6136 or jwilkinson@smi-online.co.uk \nAbout SAE Media Group Conferences: \nSAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace\, Pharmaceutical and Medical.  Each year we bring together over 5\,000 senior business professionals at our conferences. http://www.smgconferences.com \nSAE Media Group (SMG)\, a subsidiary of SAE International\, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1\,000\,000 engineers\, researchers\, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-and-injectable-drug-devices-europe/
LOCATION:London\, UK
ORGANIZER;CN="SAE Media Group":MAILTO:RJones@smi-online.co.uk
END:VEVENT
END:VCALENDAR